Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FLACL
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,812
Award facts
- Contract value 100% obligated
- $1,812.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,812.09 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price delivery order with no set-aside designation. This delivery is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00 through the DLA Troop Support Medical's ECAT Generation V Program, which runs through December 31, 2025. The contract supports the company's established role as a critical pharmaceutical supplier for U.S. Armed Forces medical operations.
Dakota Drug, Inc. has demonstrated significant capability in supplying diverse pharmaceutical and medical products to defense healthcare facilities, with a track record of delivering medications ranging from diabetes management products to vaccines and specialty therapeutics. As a self-certified small disadvantaged business registered in the System for Award Management since 2001, the company fulfills this delivery order from its Anoka, Minnesota location, continuing its strategic participation in military medical supply chain operations. The firm fixed price structure and compressed timeline reflect the urgent operational requirements typical of defense medical logistics procurement.
Quick answers
Who was awarded contract SPE2DB25FLACL?
SPE2DB25FLACL was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FLACL worth?
The government has obligated $1,812 on SPE2DB25FLACL.
Is contract SPE2DB25FLACL an order under another contract?
Yes. SPE2DB25FLACL is a delivery order under SPE2DB24D8001, an indefinite delivery contract.
Was contract SPE2DB25FLACL competed?
The extent of competition for SPE2DB25FLACL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award